Expression of a Splice Variant of CYP26B1 in Betel Quid-Related Oral Cancer
Figure 3
Expression of CYP26B1 induced by arecoline for 24 h in cultured HGF-1 and Ca9-22 cells. (a) Expression of full-length CYP26B1 (57 kDa) and the splice variant (49 kDa) in HGF-1 cells exposed to arecoline at various concentrations compared with the control, which did not receive arecoline treatment; (b) densitometric analysis of the expression of full-length CYP26B1 bands in HGF cells; (c) densitometric analysis of the expression of the CYP26B1 splice variant in HGF-1 cells; (d) expression of full-length CYP26B1 (57 kDa) and the splice variant (49 kDa) in Ca9-22 cells exposed to arecoline at various concentrations compared with the control; (e) densitometric analysis of the expression of full-length CYP26B1 bands in Ca9-22 cells; (f) densitometric analysis of the expression of the CYP26B1 splice variant in Ca9-22 cells. Mean ± SD; ; ; .
